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Introduction.R e g i o n a ld i ﬀerences for fracture risk of US Hispanics may vary by national origin. In California, where a majority
of the Hispanic population is of Mexican descent, it is of interest to compare the FRAX absolute risk using the US Hispanic and
Mexico databases. Methods. We collected FRAX risk factor data from 134 women of Mexican descent in southern California.
The FRAX risk score was calculated using the US Hispanic and Mexican databases, using the NOF guidelines for osteoporosis to
compare the number of patients that would be selected for treatment. Results. The 10-year absolute risk of major osteoporotic
fracture among women of Mexican descent using the US Hispanic database was 4.82 ± 5.03 (95% CI 3.97–5.67) compared to
4.86 ± 4.72 (CI 3.98–5.44) using the Mexico database (P = .94). The 10-year risk for hip fracture was 0.86 ± 1.78 (CI .56–1.16)
compared to 1.12 ± 1.97 (CI .79–1.45, P = .26). The mean conformity for meeting the interventional threshold by either risk
score was 94.8%. Conclusion. The comparisonbetween the FRAX databases demonstrates a similarityin the absolute risk of major
osteoporotic fracture. Diﬀerences are noted in the absolute number of hip fracture subjects at risk, but there is a high rate of
conformity.
1.Introduction
The FRAX calculator for the United States is unique in that
there exist distinct databases for ethnic minorities. However,
the addition of ethnic databases may not fully distinguish
the variability of racial, ethnic, and national origins of the
Hispanic community in the Unites States. There are regional
diﬀerences in hip fracture incidence for Hispanics within
the US [1]. For example, moving from the east coast to
the west coast, the fracture rates for Hispanics increase as
much as three-fold [1, 2]. Even though the US Hispanic
FRAX database was developed based on NHANES 3 BMD
data with oversampling for Mexican Americans [3], it may
underestimate the fracture risk for Californian Hispanics,
most of whom are of Mexican descent. Clinically, this could
leadtothepotentialundertreatment ofhigh-risk individuals.
A Mexico database was recently added to FRAX. Unlike
the US Hispanic database, which relies solely on BMD data
to estimate risk, the Mexico database is more representative
of the broader Mexican population and is based on observed
prevalence and incident rates of actual fracture events [4]. In
California, a majority of the Hispanic population is of Mex-
ican descent: of the nearly 13.5 million Hispanic residents,
84% (39% foreign born) are of Mexican descent [5]. The
similarities between Mexican and California Hispanics are
supported by the age-adjusted hip fracture incidence rates.
Incidenceratesper1,000person-years were 2.03[4]forM ex-
ican females compared to 1.97 for California Hispanics [6].
Thedatasuggestthatthereissimilarriskforfracturebetween
Mexicans and California Hispanic females that might not be
represented nationally by the US Hispanic FRAX database.
It is not known if FRAX estimates for Hispanic women in2 Journal of Osteoporosis
Southern California diﬀer between the use of either the US
Hispanic database or the Mexico database.
Our objective was to compare the number of South-
ern Californian, Mexican-American (of Mexican descent)
women who met the NOF treatment threshold using the
FRAX US Hispanic and Mexico databases.
2.Methods
FRAXclinicalrisk factor data, without BMD results, was col-
lectedfrompatientsinSouthernCalifornia[7].Subjectswere
recruited at health fairs and conferences in Burbank, Los
Angeles, Santa Barbara County, and Ventura County. Sub-
jectswerepostmenopausal,Hispanicwomengreaterthanage
40 with no history of using osteoporosis medications (per
FRAXguidelines).160surveyswerecompleted,ofwhich,134
were by women self-identiﬁed as Hispanic and of Mexican
descent.
The FRAX risk score was calculated using the US
Hispanic and Mexican databases. Conformity between the
databases was determined by comparing the number of
instances where the risk of fracture matched to the instances
where risk did not match between databases. In the US,
NOF guidelines suggest persons with low bone mass and
an FRAX score above 3% risk of hip fracture or 20% risk
of osteoporotic fracture are at high risk and should be
considered for treatment [8].
3.Results
Table 1 provides the summary of demographics and clinical
risk factor data acquired for all subjects of Mexican descent.
Subjects of Mexican descent comprised 83.8% (134 of 160)
of those surveyed. The breakdown of US native-born and
generational data is unknown. Using the US Hispanic FRAX
database the 10-year absolute risk of major osteoporotic
fracture was determined to be 4.82 ± 5.03 (95% conﬁdence
interval (CI) 3.97–5.67) and 10-year risk of hip fracture 0.86
± 1.78 (CI .56–1.12). Using the Mexico database, the 10-
year absolute risk of major osteoporotic fracture and risk
of hip fracture was 4.86 ± 4.72 (CI 4.06–5.66) and 1.12 ±
1.97 (CI .79–1.45), respectively. The diﬀerences in averages
between the two databases for major osteoporotic fracture
(P = .9392) and hip fracture (P = .2595) are not statistically
signiﬁcant.
US NOF guidelines for osteoporosis suggest treatment
for patients with a BMD less than 1.0 and with a 10-year
hipfractureprobability≥3%ora10-yearmajorosteoporotic
fracture risk ≥20%. Because BMD data was not collected,
we only used the 20%/3% threshold determinant for inter-
vention. Using the US database, 9 subjects were identiﬁed at
high risk (Table 2). Using the Mexico database, 16 patients
were identiﬁed at high risk. The diﬀerence in absolute risk
of fracture was more pronounced based on hip fracture
risk. The mean conformity for meeting the interventional
threshold by either risk score was 94.8% (Table 3). The mean
conformity for meeting the interventional threshold based
solely on the 10-year hip fracture risk was 94.8%. The mean
Table 1: Characteristics of study subjects (n = 134).
Mean
Age 53 ±10
Height (cm) 158 ±7
Weight (kg) 72 ±13
BMI (kg/m2)2 8 .8 ±5.3
Risk factor No. (%)
Fragility fracture 37 (27.6)
Parental hip fracture 11 (8.2)
Alcohol 1 (0.7)
Smoker 6 (4.5)
Glucocorticoid use 19 (14.2)







High fracture risk for any major
osteoporotic fracture 43
High risk by hip fracture 8 16
High risk by either measure 9 16
Not at high risk by either measure 125 118
Table 3: Conformity of risk assessment between US Hispanic and









Conformity at high fracture
risk 38 9
Conformity at low fracture risk 130 118 118
High fracture risk by US
Hispanic and low by Mexico 10 0
High fracture risk by Mexico
and low by US Hispanic 08 8
Conformity (%) 99.3 94.8 94.8
conformity formeeting the threshold based solely on therisk
of any major osteoporotic fracture was 99.3%.
4.Discussion
The data for the US Hispanic database was extrapolated
from BMD and risk factor data from NHANES III [9].
The diﬃculty in using national data lies in the diversity
of the Hispanic community in the USA. The ethnic term
“Hispanic” has been deﬁned to include an person of Cuban,
Mexican, Puerto Rican, South or Central American, or
other Spanish culture or origin, regardless of race [10].
However, even though individuals are classiﬁed as Hispanic,
many Puerto Ricans and Cubans self-identify as African-
American, black or Afro-Caribbean. The FRAX database
for Hispanic Americans cannot account for the variabilityJournal of Osteoporosis 3
of incident fracture rates across the United States. The
US Hispanic database, while oversampled for Mexican-
Americans, includes data from other Hispanic racial groups.
Because of this, Hispanics cannot be considered as a singular
group, and treating patients needs to be aligned more closely
with race and national origin.
This study has several limitations. Ultimately, it remains
unknown which database more accurately reﬂects the actual
risk of fracture for Hispanic women in Southern California.
This information can only be determined by observing
fractures prospectively. Additionally, the dataset is limited to
only 134 subjects. This study needs to be repeated with a
larger dataset.
5.Conclusion
The comparison between the Mexican and US Hispanic
FRAX databases demonstrates a similarity in the absolute
risk of major osteoporotic fracture. Diﬀerences are noted
in the absolute number of hip fracture subjects at risk, but
there is a high rate of conformity. Further research is needed
to determine the role and generational limitations of using
ancestry and country of origin.
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